TRIP6: Thyroid Hormone Receptor Interactor 6 – Gene Overview

Comprehensive biomedical profile of TRIP6, a Zyxin family member involved in transcriptional regulation, cell migration, and cancer signaling.

Gene Information Card

Symbol TRIP6
Full Name Thyroid Hormone Receptor Interactor 6
Gene Type Protein coding
Chromosomal Location 7q22.1
NCBI Gene ID 7205 ncbi.nlm.nih.gov/gene/7205
Ensembl ID ENSG00000106031
UniProt ID Q15654
OMIM ID 602529
HGNC ID 12311
Aliases ZRP-1, OIP1, TRIP-6

Description

TRIP6 (Thyroid Hormone Receptor Interactor 6) is a protein-coding gene belonging to the zyxin family of LIM domain-containing proteins. It functions as a transcriptional coactivator for thyroid hormone receptor and other nuclear receptors, and plays a role in cell adhesion, migration, and signal transduction. TRIP6 localizes to focal adhesions and shuttles between the cytoplasm and nucleus to modulate gene expression. Overexpression and mutations have been implicated in various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer TRIP6 overexpression promotes cell migration and invasion via focal adhesion kinase (FAK) signaling. PMID: 20628086
Colorectal cancer TRIP6 upregulation correlates with tumor progression and poor prognosis; enhances Wnt/β-catenin signaling. PMID: 25242043
Glioma TRIP6 expression is elevated and associated with increased cell proliferation and migration. PMID: 29367642
Ovarian cancer TRIP6 contributes to metastatic potential through regulation of actin cytoskeleton dynamics. PMID: 23542344

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 17.3 Medium
Breast 12.8 Medium
Colon 15.1 Medium
Ovary 9.5 Low
Brain 6.2 Low
Liver 8.9 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 14.5 Moderate expression
HCT116 (colorectal cancer) 18.2 High expression
A549 (lung cancer) 16.0 Moderate expression
U87MG (glioma) 11.3 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.1% Unknown functional effect; reported in COSMIC
c.1246G>A (p.Glu416Lys) Missense <0.1% Located in LIM domain; potential impact on protein-protein interactions
c.148_149insA (p.Thr50Asnfs*12) Frameshift <0.1% Predicted loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., c.148_149insA) are predicted to cause premature truncation and loss of LIM domains, impairing transcriptional coactivator function.

Gain of Function (GOF)

Missense mutations in the LIM domains may enhance protein stability or alter binding partners, potentially contributing to oncogenic signaling.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for TRIP6.

Pathways

Focal adhesion (KEGG: hsa04510)
Wnt signaling pathway (KEGG: hsa04310)
Thyroid hormone signaling pathway (KEGG: hsa04919)
Regulation of actin cytoskeleton (KEGG: hsa04810)

Protein Summary

TRIP6 encodes a 476-amino acid protein with three C-terminal LIM domains and a proline-rich N-terminal region. It localizes to focal adhesions and interacts with thyroid hormone receptor, FAK, and other signaling molecules. TRIP6 shuttles to the nucleus to act as a transcriptional coactivator. Its expression is elevated in several cancers, where it promotes cell migration, invasion, and proliferation.

Related Products

Product name Cat.No. Species Gene ID
TRIP6 Knockout HEK293 Cell Line EDJ-KQ5963 Human 7205 Details Get a Quote
TRIP6 Knockout A-549 Cell Line EDJ-KQ29531 Human 7205 Details Get a Quote
TRIP6 Knockout HCT 116 Cell Line EDJ-KQ29532 Human 7205 Details Get a Quote
TRIP6 Knockout HeLa Cell Line EDJ-KQ29533 Human 7205 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: